Abstract
The core-fucosylated (CF) glycoproteins are widely distributed in mammalian tissues and regulated under pathological conditions, especially in cancer progression. The Food and Drug Administration (FDA) has approved the core-fucosylated α-fetoprotein as a biomarker for the early diagnosis of hepatocellular carcinoma (HCC). An approach for identifying CF glycoproteins has significantly practical value. Here we introduce a novel method for identification of CF glycoproteome in human plasma. The method integrates tandem glycopeptide enrichment, stepped fragmentation, and “glycan diagnostic ion”-based spectrum refinement. With this method, the productivity of identifying CF glycopeptides will be significantly improved. We anticipate that this method could be widely utilized to explore the CF glycoproteins and their regulation under physiological or pathological condition.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Block TM, Comunale MA, Lowman M et al (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 102:779–784
Comunale MA, Lowman M, Long RE et al (2006) Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 5:308–315
Okuyama N, Ide Y, Nakano M et al (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118:2803–2808
Barrabes S, Pages-Pons L, Radcliffe CM et al (2007) Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 17:388–400
Geng F, Shi BZ, Yuan YF et al (2004) The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications. Cell Res 14:423–433
Wang X, Inoue S, Gu J et al (2005) Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci U S A 102:15791–15796
Saldova R, Royle L, Radcliffe CM et al (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17:1344–1356
Tabares G, Radcliffe CM, Barrabes S et al (2006) Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 16:132–145
Zhao Y, Jia W, Wang J et al (2011) Fragmentation and site-specific quantification of core fucosylated glycoprotein by multiple reaction monitoring-mass spectrometry. Anal Chem 83:8802–8809
Comunale MA, Wang M, Hafner J et al (2009) Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res 8:595–602
Cao Q, Zhao X, Zhao Q et al (2014) Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry. Anal Chem 86:6804–6811
Chen R, Wang F, Tan Y et al (2012) Development of a combined chemical and enzymatic approach for the mass spectrometric identification and quantification of aberrant N-glycosylation. J Proteomics 75:1666–1674
Jia W, Lu Z, Fu Y et al (2009) A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol Cell Proteomics 8:913–923
Tarentino AL, Plummer TH Jr (1994) Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol 230:44–57
Plummer TH Jr, Phelan AW, Tarentino AL (1996) Porcine fibrinogen glycopeptides: substrates for detecting endo-beta-N-acetylglucosaminidases F2 and F3(1). Anal Biochem 235:98–101
Tarentino AL, Quinones G, Plummer TH Jr (1995) Overexpression and purification of non-glycosylated recombinant endo-beta-N-acetylglucosaminidase F3. Glycobiology 5:599–601
Trimble RB, Tarentino AL, Plummer TH Jr et al (1978) Asparaginyl glycopeptides with a low mannose content are hydrolyzed by endo-beta-N-acetylglucosaminidase H. J Biol Chem 253:4508–4511
Acknowledgments
This work was supported by the grants from the National Key Program for Basic Research of China (2014CBA02001, 2016YFA0501300) and the National Natural Science Foundation of China (81530021, 21505151).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Cao, Q., Zhao, Q., Qian, X., Ying, W. (2017). Identification of Core-Fucosylated Glycoproteome in Human Plasma. In: Greening, D., Simpson, R. (eds) Serum/Plasma Proteomics. Methods in Molecular Biology, vol 1619. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7057-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7057-5_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7056-8
Online ISBN: 978-1-4939-7057-5
eBook Packages: Springer Protocols